Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bovine hemoglobin is a heterotetrameric metalloprotein found in cattle red blood cells, consisting of two alpha and two beta subunits (UniProt P01966, P02070). Each subunit contains a heme prosthetic group with a central ferrous iron atom that coordinates diatomic ligands like O2, CO, and NO (PubChem CID 16212488). In the biotech industry, bovine hemoglobin is a critical scaffold for developing Hemoglobin-Based Oxygen Carriers (HBOCs), such as the glutaraldehyde-polymerized Hemopure, designed to provide oxygenation in patients where red blood cell transfusion is not feasible (FDA, Hemopure). The interaction with carbon monoxide is particularly significant; CO binds to the heme iron with an affinity roughly 200 times that of oxygen, forming carboxyhemoglobin and shifting the oxygen dissociation curve to the left (StatPearls, Carbon Monoxide Toxicity). While this interaction is the mechanism of CO poisoning, it is also being leveraged therapeutically through CO-releasing molecules (CORMs) and products like Sanguinate (PEGylated bovine carboxyhemoglobin) to exploit CO's anti-inflammatory and cytoprotective properties in conditions like ischemia-reperfusion injury (PubMed, PMID: 15936010). Structural studies of the CO-bound form, such as those documented in PDB 1COB, are essential for understanding the allosteric transitions (T to R state) that govern ligand affinity and protein stability (Journal of Molecular Biology). However, therapeutic use of bovine hemoglobin faces challenges, including nitric oxide scavenging which leads to systemic hypertension and the potential for renal toxicity from dissociated hemoglobin dimers (PubMed, PMID: 11753340). Furthermore, the immunogenicity of bovine-derived proteins remains a concern for long-term or repeated administration in humans.
Reversible coordination of diatomic ligands to the ferrous iron atom in the heme group, regulated by allosteric transitions between the T (tense) and R (relaxed) conformational states.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemoglobin (Bovine) (bHb).